greeksoup/ stock research

SBC Medical Group Holdings (SBC) Q3 FY2026 earnings: revenue $59 million, up 35.1% on the year

SBC Medical Group Holdings Inc. (SBC) reported revenue of $59 million for Q3 FY2026, the quarter ended 30 September 2026, up 35.1% on the same quarter a year earlier. Net income was $16 million, up 22.4% on the year, and diluted earnings per share $0.15. The figures are the company's own, from the 10-Q it filed with the SEC on 13 November 2026.

Revenue
$59 million
+35.1% on the year · +19.1% on the quarter
Q4 FY2024Q3 FY2026
Operating margin
45.1%
36.6% a year earlier
Q4 FY2024Q3 FY2026
Net income
$16 million
+22.4% on the year · +46.8% on the quarter
Q4 FY2024Q3 FY2026
Diluted EPS
$0.15
+25.0% on the year · +50.0% on the quarter
Q4 FY2024Q3 FY2026

this quarterthe same quarter a year earlierHover a bar for its figure.

What management said

  • Revenue rose 35% in the quarter: Quarterly revenue was $59 million, up 35% year-over-year.
  • Operating income rose 66%: Income from operations was $26 million, with a 45% operating margin, compared with $15.9 million a year earlier.
  • Clinic network reached 293 locations: The clinic network had 293 locations at September 30, 2026, up 36 year-over-year across the support and partnership network.
Read the earnings call summary

Income statement (profit and loss)

$ millionQ3 FY2026Q2 FY2026Q3 FY2025On the quarterOn the yearLast 8 quarters
Revenue58.649.243.4+19.1%+35.1%
Cost of revenue16.413.212.7+24.2%+28.7%
Gross profit42.236.030.6+17.2%+37.8%
Gross margin72.0%73.1%70.6%
Selling, general and administrative15.817.014.7-7.4%+7.0%
Operating income26.419.015.9+39.3%+66.3%
Operating margin45.1%38.5%36.6%
Interest expense0.10.10.0+0.5%+182.6%
Pre-tax income26.419.618.5+34.9%+42.5%
Income tax9.47.85.7+19.9%+65.3%
Effective tax rate35.5%40.0%30.7%
Net income15.710.712.8+46.8%+22.4%
Net margin26.8%21.7%29.6%
Diluted EPS$0.15$0.10$0.12+50.0%+25.0%
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionQ3 FY2026Q2 FY2026Q3 FY2025On the quarterOn the yearLast 8 quarters
Operating cash flow18.522.5-20.9-17.8%
Capital expenditure1.00.10.0+1,090.9%+2,234.4%
Free cash flow17.522.4-20.9-22.0%
Free cash flow margin29.9%45.6%-48.3%
Cash from investing-5.10.6-12.2
Cash from financing-5.1-2.011.6
Depreciation and amortisation1.21.10.7+4.5%+61.4%
Share-based compensation0.0n/a0.0
Buybacks0.0n/a2.6
Diluted shares, weighted103m103m103m0.0%-0.1%
Shares outstanding at period end103m103m103m0.0%0.0%

Cash flow lines for the quarter; where the company files them year to date, the quarter is the difference between two filings.

Balance sheet

$ millionQ3 FY2026Q2 FY2026Q3 FY2025On the quarterOn the yearLast 8 quarters
Shareholders' equity287264248+8.7%+15.7%
Non-controlling interest16.616.10.1+3.4%+23,344.6%
Debt33.637.822.8-11.0%+47.6%
Operating lease liabilities4.54.91.6-7.3%+190.3%
Finance lease liabilities0.10.10.1-18.5%-54.0%
Other liabilities83.184.048.8-1.0%+70.2%
Total liabilities and equity425407321+4.5%+32.2%
Fixed assets8.57.47.0+15.0%+21.9%
Goodwill15.115.24.9-0.7%+206.1%
Intangible assets45.245.723.3-1.0%+94.1%
Investments2.21.6n/a+37.8%
Cash and equivalents198184127+7.7%+55.7%
Inventory2.93.01.7-1.0%+75.8%
Other assets152149157+2.0%-2.9%
Total assets425407321+4.5%+32.2%

Questions

What was SBC Medical Group Holdings' revenue in Q3 FY2026?

SBC Medical Group Holdings (SBC) reported revenue of $59 million for Q3 FY2026, the quarter ended 30 September 2026, up 35.1% on the same quarter a year earlier.

How much did SBC Medical Group Holdings earn in Q3 FY2026?

Net income for Q3 FY2026 was $16 million, up 22.4% on the year, and diluted earnings per share $0.15.

When did SBC Medical Group Holdings report Q3 FY2026 results?

SBC Medical Group Holdings filed its 10-Q for the quarter ended 30 September 2026 with the SEC on 13 November 2026.

Quarterly results, the last 12 quarters

Q3 FY2023Q1 FY2024Q2 FY2024Q3 FY2024Q4 FY2024 *Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025 *Q1 FY2026Q2 FY2026Q3 FY2026
Revenue47.354.853.153.144.447.343.443.439.643.149.258.6
Cost of revenue13.815.313.79.810.59.613.312.710.612.713.216.4
Gross profit33.539.539.443.233.937.730.030.628.930.336.042.2
Gross margin71%72%74%81%76%80%69%71%73%70%73%72%
SG&A13.415.112.116.613.913.515.514.716.112.617.015.8
Operating income20.024.527.313.84.724.214.615.912.817.719.026.4
Operating margin42%45%51%26%11%51%34%37%32%41%39%45%
Interest expense0.00.00.00.00.00.00.00.00.10.10.10.1
Pre-tax income21.127.227.113.16.131.513.518.518.618.919.626.4
Tax rate62%31%31%78%-8%32%82%31%23%40%40%36%
Net income8.418.818.52.86.521.52.512.814.211.310.715.7
Net margin18%34%35%5%15%45%6%30%36%26%22%27%
Diluted EPS$0.09$0.20$0.20$0.03$0.05$0.21$0.02$0.12$0.14$0.11$0.10$0.15
Operating cash flown/a3.719.25.0-7.31.9-8.3-20.952.09.222.518.5
Capital expendituren/a0.70.90.40.60.30.30.00.80.10.11.0
Free cash flown/a3.018.34.6-7.91.7-8.6-20.951.29.122.417.5
Buybacksn/an/an/an/an/an/an/a2.6n/an/an/a0.0
Shares outstanding103m104m104m103m103m104m103m103m103m103m103m103m
Filing10-Q10-Q10-Q10-Q10-K10-Q10-Q10-Q10-K10-Q10-Q10-Q
Each quarter as filed, linked to its filing.
Read more* The fourth quarter is the full year less the first three quarters, because the company files the year and not the quarter on its own. A fourth quarter's EPS, and its diluted share count where shown, are from the company's results press release for that quarter, checked against the company's filed figures or a second data source. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and the share count are as they are. Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Cash flow lines filed year to date are the difference between two filings. Shares outstanding are at the period end where the balance sheet tags them, otherwise the count on the filing's cover page. A derived fourth-quarter EPS is left blank when a split in the year makes the arithmetic meaningless.

10-Q for the period ended 30 September 2026, filed 13 November 2026: the filing.